Search

Search Language

English | Use language selector above (below, on mobile) to search additional languages

Open filter

188 items matching filters

Search Results

Insight

Senate Bill Unexpectedly Proposes Significant Expansion of QSBS Benefits

by SeoJung Park, Peter Elias and Eric Wall
2 minute read | June.17.2025

The Senate Finance Committee introduced a bill that would significantly expand the benefits available for qualified small business stock (QSBS).

Insight

The Supreme Court Issues a Major Course Correction, Limiting The Role of Federal Courts in NEPA Cases

by Robert Loeb, Lisa Tonery, Jodie Liu and Geoffrey Shaw
5 minute read | May.30.2025

We break down how the Supreme Court’s evolving approach to agency deference will impact environmental reviews and project permitting under NEPA.

Insight

TAKE IT DOWN Act Becomes Law, Introducing Landmark Federal Protections to Combat Online Exploitation and Deepfakes

by Aravind Swaminathan, Jacob M. Heath, Meg Hennessey, David Curtis, Ryann Rae McMurry and Tom Zick
4 minute read | May.21.2025

The Act is the first significant bipartisan federal legislation focused on protections against the spread of non-consensual intimate imagery.

Insight

How Shifting Trade Dynamics Are Reshaping U.S. Healthcare | Life Sciences Snapshot – Q2 2025

11 minute read | May.12.2025

The Q2 2025 Life Sciences Snapshot highlights strong Q1 VC trends, rising valuations, IPO growth, and a roundtable on trade impacts to U.S. ...

Insight

SEC Issues Guidance on Use of Minimum Investment Amounts for Verifying Accredited Investor Status Under Rule 506(c)

by Dolph Hellman and Kenneth Rasamny
2 minute read | March.19.2025

Recent guidance from the SEC provides greater flexibility and clarity for issuers in verifying accredited investor status under Rule 506(c).

Insight

Telehealth Transformation: Innovating Mental Health Care
Life Sciences Snapshot – Q1 2025

11 minute read | February.19.2025

Life Sciences Snapshot – Q1 2025 – A Quarterly Report on Financing Trends

U.S. life sciences VC rebounded in 2024 with rising deal and exit value. Orrick’s Life Sciences Snapshot breaks down the key trends.

Insight

Q&A: Will States Take the Lead in Consumer Protection?

by Amanda Lawrence, John Coleman, Clinton Rockwell, John (Jay) Williams, Kathryn Ryan, Jedd Bellman and Olivia Ragoowansi
4 minute read | February.11.2025

With the CFPB on pause for now, we explore key questions about how the consumer financial services regulatory landscape appears to be shifting.

Insight

Will State-Level Consumer Protection Activity Increase Amid CFPB Shakeup?

by Amanda Lawrence, John Coleman, Clinton Rockwell, John (Jay) Williams, Kathryn Ryan, Jedd Bellman and Olivia Ragoowansi
8 minute read | February.10.2025

As the CFPB undergoes significant transition, certain state financial regulators and attorneys general appear poised to step into the Bureau’s shoes.

Insight

California Battery Fires: Mitigating Commercial Risks in BESS Transactions

by Patrick Ferguson, Rohit Sachdev and Eric Stephens
5 minute read | February.06.2025

California regulators are adopting stricter measures and proposing sweeping reforms and legislation that could impact utility-scale BESS development.

Insight

Navigating the California AI Transparency Act: New Contract Requirements

by Sarah Schaedler and Haley Flora
4 minute read | January.31.2025

Companies that create or produce a generative AI system with more than 1 million monthly users face new contracting requirements.

Insight

Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends

14 minute read | December.20.2024

Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market

Insight

The Post-Election Outlook for State Financial Regulation

1 hour watch | December.03.2024

Join Team Orrick for a conversation about anticipated financial regulatory, enforcement and policy-making priorities at the state level.